These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 18035428

  • 1. Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock.
    Goris N, Vandenbussche F, De Clercq K.
    Antiviral Res; 2008 Apr; 78(1):170-8. PubMed ID: 18035428
    [Abstract] [Full Text] [Related]

  • 2. Highly pathogenic RNA viral infections: challenges for antiviral research.
    Bray M.
    Antiviral Res; 2008 Apr; 78(1):1-8. PubMed ID: 18243346
    [Abstract] [Full Text] [Related]

  • 3. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M, Füssel AE.
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [Abstract] [Full Text] [Related]

  • 4. 2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus.
    Goris N, De Palma A, Toussaint JF, Musch I, Neyts J, De Clercq K.
    Antiviral Res; 2007 Mar; 73(3):161-8. PubMed ID: 17055073
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo.
    Kim SM, Lee KN, Park JY, Ko YJ, Joo YS, Kim HS, Park JH.
    Antiviral Res; 2008 Nov; 80(2):178-84. PubMed ID: 18601955
    [Abstract] [Full Text] [Related]

  • 6. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle.
    Jamal SM, Bouma A, van den Broek J, Stegeman A, Chénard G, Dekker A.
    Vaccine; 2008 Nov 25; 26(50):6317-21. PubMed ID: 18822336
    [Abstract] [Full Text] [Related]

  • 7. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL, Paton DJ, Rieder E, Barnett PV.
    Vaccine; 2008 Apr 07; 26(16):1982-9. PubMed ID: 18342409
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural analysis of foot-and-mouth disease virus 3C protease: a viable target for antiviral drugs?
    Curry S, Roqué-Rosell N, Sweeney TR, Zunszain PA, Leatherbarrow RJ.
    Biochem Soc Trans; 2007 Jun 07; 35(Pt 3):594-8. PubMed ID: 17511659
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Foot-and-mouth disease control using vaccination: South African experience.
    Brückner GK, Vosloo W, Cloete M, Dungu B, Du Plessis BJ.
    Dev Biol (Basel); 2004 Jun 07; 119():51-62. PubMed ID: 15742618
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers.
    Vagnozzi A, Stein DA, Iversen PL, Rieder E.
    J Virol; 2007 Nov 07; 81(21):11669-80. PubMed ID: 17728223
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.